Irizarry MC

References (5)

Title : Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study - Fitzpatrick_2014_Atherosclerosis_235_384
Author(s) : Fitzpatrick AL , Irizarry MC , Cushman M , Jenny NS , Chi GC , Koro C
Ref : Atherosclerosis , 235 :384 , 2014
PubMedID: 24929287

Title : Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study - Davidson_2012_Alzheimers.Res.Ther_4_51
Author(s) : Davidson JE , Lockhart A , Amos L , Stirnadel-Farrant HA , Mooser V , Sollberger M , Regeniter A , Monsch AU , Irizarry MC
Ref : Alzheimers Res Ther , 4 :51 , 2012
PubMedID: 23217243

Title : Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease - Irizarry_2007_Neurodegener.Dis_4_403
Author(s) : Irizarry MC , Yao Y , Hyman BT , Growdon JH , Pratico D
Ref : Neurodegener Dis , 4 :403 , 2007
PubMedID: 17934322

Title : Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels - Fukumoto_2003_Arch.Neurol_60_958
Author(s) : Fukumoto H , Tennis M , Locascio JJ , Hyman BT , Growdon JH , Irizarry MC
Ref : Archives of Neurology , 60 :958 , 2003
PubMedID: 12873852

Title : Alzheimer disease therapeutics - Irizarry_2001_J.Neuropathol.Exp.Neurol_60_923
Author(s) : Irizarry MC , Hyman BT
Ref : J Neuropathol Experimental Neurology , 60 :923 , 2001
PubMedID: 11589422